Hosted on MSN7h
Genprex doses first subject in expansion part of lung cancer gene therapy trial
Genprex has dosed the first subject in the Phase II expansion portion of its Acclaim-3 trial of the Reqorsa gene therapy ...
Bomboré Production Expansion Ahead of Schedule and on Budget
Engineering is ahead of schedule, with all bulk quantities in line with budget. Procurement is at 82% of total supply value ...
montanafreepress2d
Medicaid expansion bills spur hours of testimony in first hearings
Lawmakers in both chambers Wednesday considered the future of the low-income health care program, set to expire if they don’t ...
Arnold Palmer airport expansion project on track to take off in December
A new terminal for passengers at Arnold Palmer Regional Airport is on track for completion by Christmas. Officials said ...
FiercePharma11h
Fujifilm Diosynth CEO heralds 2025 as 'biggest year' yet for CDMO's $8B+ expansion drive
By August or September of this year, Petersen said he expects “basically half” of the company’s $8 billion in manufacturing ...
appliedclinicaltrialsonline1d
First Patient Dosed in Phase II Expansion Portion of Acclaim-3 Trial of Reqorsa in Combination With Tecentriq
In the Phase I dose escalation portion, which evaluated the combination in participants with small cell lung cancer, the first patient treated attained partial remission.